Surgical Procedure That Can Slow Knee Osteoarthritis Progression

A groundbreaking study shows that high tibial osteotomy (HTO) surgery can slow the progression of knee osteoarthritis, offering hope for disease modification and improved patient outcomes.
A recent clinical trial conducted by the London Health Sciences Centre Research Institute and Western University has demonstrated that high tibial osteotomy (HTO), a precise surgical procedure, can significantly decelerate the progression of knee osteoarthritis. This surgery involves realigning the shinbone to reduce stress on the damaged parts of the knee joint, particularly benefiting patients with bowed legs—a known risk factor for disease advancement. The study, published in the "Annals of Internal Medicine," followed patients for two years, comparing outcomes between those who underwent HTO alongside non-surgical management and those who received only conservative treatment.
The results revealed that patients who received the surgery showed less cartilage deterioration, better walking mechanics, reduced pain, and improved quality of life. Advanced imaging techniques like MRI and gait analysis confirmed that the procedure resulted in a marked decrease in joint damage, with an average loss of only 2% of articular cartilage compared to 9% in non-surgical patients.
Dr. Trevor Birmingham, a lead researcher, emphasized that this procedure could modify the disease's course by changing how the knee bears weight during movement. Dr. J Robert Giffin, an orthopedic surgeon involved in the study, expressed optimism that more surgical centers would adopt HTO, given its potential to alter the disease trajectory and reduce disability caused by osteoarthritis.
Osteoarthritis remains the most common joint disorder worldwide, affecting over 500 million people and predominantly targeting the knees. Until now, treatments focused mainly on symptom relief, with limited options to halt or reverse the progression. The findings from this study open new avenues for disease-modifying surgical interventions that could benefit a large patient population.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Key Gene Expression Disruption Central to ALS Development Unveiled
A groundbreaking study uncovers the central role of UNC13A gene regulation in ALS development, revealing shared molecular pathways that could guide new treatments for this devastating disease.
Proposed Framework to Shield Patients from Risks of High-Impact Brain Implants
A new proposal advocates for a no-fault compensation system to support patients harmed by high-risk brain implants, ensuring safety and justice as neural interface technologies advance.
New Hope for Treating Obesity-Related Breathing Disorders with Setmelanotide
This innovative research highlights the potential of setmelanotide, an FDA-approved drug, in treating obesity-linked sleep breathing disorders by targeting brain pathways that regulate respiration.



